Document is current
Any future updates will be listed below
-
Authors
Parsons, Susan K. https://orcid.org/0000-0003-0282-6490
Rodday, Angie Mae
Pei, Qinglin
Keller, Frank G.
Wu, Yue
Henderson, Tara O.
Cella, David
Kelly, Kara M.
Castellino, Sharon M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02166463 at ClinicalTrials.govDocuments that mention this clinical trial
Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study
https://doi.org/10.1186/s41687-023-00653-0
Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study
https://doi.org/10.1200/jco.24.00038
-
Funding
Funding for this research was provided by:
National Institutes of Health to the Children’s Oncology Group (U10CA098543)
NCTN Statistics and Data Center Grant (U10CA180899)
NCTN Operations Center Grant (U10CA180886)
the NCORP grant (UG1CA189955)
St. Baldrick's Foundation
Leukemia and Lymphoma Society
Seagen
- License Information
-
More Information
Article History
Received: 15 May 2023
Accepted: 1 November 2023
First Online: 10 November 2023
Declarations
:
: NCI cIRB with local institutional review and approval prior to study opening.
: Official sign off by COG, NCI (NCORP and CTEP), and industry partners.
: The authors declare that they have no competing interests.
